TY  - JOUR
AU  - Fernández, Óscar
PY  - 2016
DO  - 10.1159/000444234
UR  - http://hdl.handle.net/10668/9855
T2  - European neurology
AB  - From the time Sativex (THC:CBD) oromucosal spray first became available in European Union countries in 2010 for the management of treatment-resistant multiple sclerosis (MS) spasticity, data from daily practice have been collected through various...
LA  - en
KW  - Accidental Falls
KW  - Cannabidiol
KW  - Depression
KW  - Dronabinol
KW  - Drug Combinations
KW  - Germany
KW  - Humans
KW  - Marijuana Abuse
KW  - Medical Marijuana
KW  - Multiple Sclerosis
KW  - Muscle Spasticity
KW  - Oral Sprays
KW  - Plant Extracts
KW  - Prospective Studies
KW  - Registries
KW  - Retrospective Studies
KW  - Spain
KW  - Switzerland
KW  - Treatment Outcome
KW  - United Kingdom
TI  - THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.
TY  - research article
VL  - 75 Suppl 1
ER  -